Literature DB >> 29180604

Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes.

Jonathan M Loree1, Allan A L Pereira1, Michael Lam1, Alexandra N Willauer1, Kanwal Raghav1, Arvind Dasari1, Van K Morris1, Shailesh Advani1, David G Menter1, Cathy Eng1, Kenna Shaw2, Russell Broaddus3, Mark J Routbort4, Yusha Liu5, Jeffrey S Morris5, Rajyalakshmi Luthra4, Funda Meric-Bernstam6, Michael J Overman1, Dipen Maru3, Scott Kopetz7.   

Abstract

Purpose: Colorectal cancers are classified as right/left-sided based on whether they occur before/after the splenic flexure, with established differences in molecular subtypes and outcomes. However, it is unclear if this division is optimal and whether precise tumor location provides further information.Experimental Design: In 1,876 patients with colorectal cancer, we compared mutation prevalence and overall survival (OS) according to side and location. Consensus molecular subtype (CMS) was compared in a separate cohort of 608 patients.
Results: Mutation prevalence differed by side and location for TP53, KRAS, BRAFV600, PIK3CA, SMAD4, CTNNB1, GNAS, and PTEN Within left- and right-sided tumors, there remained substantial variations in mutation rates. For example, within right-sided tumors, RAS mutations decreased from 70% for cecal, to 43% for hepatic flexure location (P = 0.0001), while BRAFV600 mutations increased from 10% to 22% between the same locations (P < 0.0001). Within left-sided tumors, the sigmoid and rectal region had more TP53 mutations (P = 0.027), less PIK3CA (P = 0.0009), BRAF (P = 0.0033), or CTNNB1 mutations (P < 0.0001), and less MSI (P < 0.0001) than other left-sided locations. Despite this, a left/right division preceding the transverse colon maximized prognostic differences by side and transverse colon tumors had K-modes mutation clustering that appeared more left than right sided. CMS profiles showed a decline in CMS1 and CMS3 and rise in CMS2 prevalence moving distally.Conclusions: Current right/left classifications may not fully recapitulate regional variations in tumor biology. Specifically, the sigmoid-rectal region appears unique and the transverse colon is distinct from other right-sided locations. Clin Cancer Res; 24(5); 1062-72. ©2017 AACRSee related commentary by Dienstmann, p. 989. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29180604      PMCID: PMC5844818          DOI: 10.1158/1078-0432.CCR-17-2484

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  23 in total

1.  Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

Authors:  S Y Brulé; D J Jonker; C S Karapetis; C J O'Callaghan; M J Moore; R Wong; N C Tebbutt; Cr Underhill; D Yip; J R Zalcberg; D Tu; R A Goodwin
Journal:  Eur J Cancer       Date:  2015-05-12       Impact factor: 9.162

2.  Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers.

Authors:  Yuan-Tzu Lan; Lin Jen-Kou; Chien-Hsing Lin; Shung-Haur Yang; Chun-Chi Lin; Huann-Sheng Wang; Wei-Shone Chen; Tzu-Chen Lin; Jeng-Kai Jiang; Shih-Ching Chang
Journal:  J Surg Oncol       Date:  2015-06       Impact factor: 3.454

3.  Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability.

Authors:  Cristina Albuquerque; Célia Baltazar; Bruno Filipe; Filipa Penha; Teresa Pereira; Ron Smits; Marília Cravo; Pedro Lage; Paulo Fidalgo; Isabel Claro; Paula Rodrigues; Isabel Veiga; José Silva Ramos; Isabel Fonseca; Carlos Nobre Leitão; Riccardo Fodde
Journal:  Genes Chromosomes Cancer       Date:  2010-08       Impact factor: 5.006

4.  The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.

Authors:  Julian Walter Holch; Ingrid Ricard; Sebastian Stintzing; Dominik Paul Modest; Volker Heinemann
Journal:  Eur J Cancer       Date:  2016-11-29       Impact factor: 9.162

5.  Primary tumor location as a prognostic factor in metastatic colorectal cancer.

Authors:  Fotios Loupakis; Dongyun Yang; Linda Yau; Shibao Feng; Chiara Cremolini; Wu Zhang; Martin K H Maus; Carlotta Antoniotti; Christiane Langer; Stefan J Scherer; Thomas Müller; Herbert I Hurwitz; Leonard Saltz; Alfredo Falcone; Heinz-Josef Lenz
Journal:  J Natl Cancer Inst       Date:  2015-02-24       Impact factor: 13.506

6.  Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials.

Authors:  Funda Meric-Bernstam; Lauren Brusco; Kenna Shaw; Chacha Horombe; Scott Kopetz; Michael A Davies; Mark Routbort; Sarina A Piha-Paul; Filip Janku; Naoto Ueno; David Hong; John De Groot; Vinod Ravi; Yisheng Li; Raja Luthra; Keyur Patel; Russell Broaddus; John Mendelsohn; Gordon B Mills
Journal:  J Clin Oncol       Date:  2015-05-26       Impact factor: 44.544

7.  Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses of the CRYSTAL and FIRE-3 Trials.

Authors:  Sabine Tejpar; Sebastian Stintzing; Fortunato Ciardiello; Josep Tabernero; Eric Van Cutsem; Frank Beier; Regina Esser; Heinz-Josef Lenz; Volker Heinemann
Journal:  JAMA Oncol       Date:  2017-02-01       Impact factor: 31.777

8.  Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.

Authors:  Sabine Venderbosch; Iris D Nagtegaal; Tim S Maughan; Christopher G Smith; Jeremy P Cheadle; David Fisher; Richard Kaplan; Philip Quirke; Matthew T Seymour; Susan D Richman; Gerrit A Meijer; Bauke Ylstra; Danielle A M Heideman; Anton F J de Haan; Cornelis J A Punt; Miriam Koopman
Journal:  Clin Cancer Res       Date:  2014-08-19       Impact factor: 12.531

9.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

10.  Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases.

Authors:  Jing Zhang; Jianming Zheng; Yinghong Yang; Junliang Lu; Jie Gao; Tao Lu; Jian Sun; Hui Jiang; Yan Zhu; Yuhui Zheng; Zhiyong Liang; Tonghua Liu
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

View more
  76 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 2.  Right Versus Left Colon Cancer: Resectable and Metastatic Disease.

Authors:  Michele Ghidini; Fausto Petrelli; Gianluca Tomasello
Journal:  Curr Treat Options Oncol       Date:  2018-05-23

Review 3.  Colorectal Cancer: Why Does Side Matter?

Authors:  Claire Gallois; Simon Pernot; Aziz Zaanan; Julien Taieb
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

4.  The Art of War and oncology: applying the principles of strategy and tactics to greater effect in the era of targeted therapy.

Authors:  Emil Lou
Journal:  Ann Transl Med       Date:  2018-05

5.  Clinical and molecular characterization of early-onset colorectal cancer.

Authors:  Alexandra N Willauer; Yusha Liu; Allan A L Pereira; Michael Lam; Jeffrey S Morris; Kanwal P S Raghav; Van K Morris; David Menter; Russell Broaddus; Funda Meric-Bernstam; Andrea Hayes-Jordan; Winston Huh; Michael J Overman; Scott Kopetz; Jonathan M Loree
Journal:  Cancer       Date:  2019-03-11       Impact factor: 6.860

Review 6.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

Review 7.  Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer.

Authors:  Lorena Losi; Tommaso Zanocco-Marani; Alexis Grande
Journal:  Histol Histopathol       Date:  2020-06-22       Impact factor: 2.303

8.  Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.

Authors:  John Virostko; Anna Capasso; Thomas E Yankeelov; Boone Goodgame
Journal:  Cancer       Date:  2019-07-22       Impact factor: 6.860

9.  Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum.

Authors:  Liang Wang; Chun-Han Lo; Xiaosheng He; Dong Hang; Molin Wang; Kana Wu; Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Mingyang Song
Journal:  Gastroenterology       Date:  2020-04-01       Impact factor: 22.682

Review 10.  Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Authors:  David G Menter; Jennifer S Davis; Bradley M Broom; Michael J Overman; Jeffrey Morris; Scott Kopetz
Journal:  Curr Gastroenterol Rep       Date:  2019-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.